{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T09:15:20Z","timestamp":1777972520566,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>On March 11<jats:sup>th<\/jats:sup>, 2020, the World Health Organization (WHO) declared the coronavirus disease 2019 (COVID-19) a pandemic. To control the pandemic, billions of vaccine doses have been administered worldwide. Predictors of COVID-19 vaccine-related side effects are inconsistently described in the literature. This study aimed to identify the predictors of side effects\u2019 severity after COVID-19 vaccination among young adult students at Taif University (TU) in Saudi Arabia. An online, anonymous questionnaire was used. Descriptive statistics were calculated for numerical and categorical variables. Possible correlations with other characteristics were identified using the chi-square test. The study included 760 young adult participants from TU. Pain at the injection site (54.7%), headache (45.0%), lethargy and fatigue (43.3%), and fever (37.5%) were the most frequently reported COVID-19 vaccine-related side effects after the first dose. The most frequent side effects were reported among the 20\u201325-year-old age group for all doses of all vaccines. Females experienced remarkably more side effects after the second (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and third doses (<jats:italic>p<\/jats:italic>\u2009=\u20090.002). Moreover, ABO blood groups significantly correlated with vaccine-related side effects after the second dose (<jats:italic>p<\/jats:italic>\u2009=\u20090.020). The participants' general health status correlated with the side effects after the first and second doses (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 and 0.022, respectively). The predictors of COVID-19 vaccine-related side effects in young, vaccinated people were blood group B, female gender, vaccine type, and poor health status.<\/jats:p>","DOI":"10.1186\/s12879-023-08363-0","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T19:02:00Z","timestamp":1686078120000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The role of blood groups, vaccine type and gender in predicting the severity of side effects among university students receiving COVID-19 vaccines"],"prefix":"10.1186","volume":"23","author":[{"given":"Ohoud S.","family":"Almalki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman Y.","family":"Santali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulaziz A.","family":"Alhothali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf A.","family":"Ewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeer","family":"Shady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Ibrahim","family":"Fathelrahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayed F.","family":"Abdelwahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"issue":"3","key":"8363_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3390\/life11030249","volume":"11","author":"AG Mathioudakis","year":"2021","unstructured":"Mathioudakis AG, Ghrew M, Ustianowski A, Ahmad S, Borrow R, Papavasileiou LP, et al. Self-reported real-world safety and reactogenicity of COVID-19 vaccines: a vaccine recipient survey. Life. 2021;11(3):249.","journal-title":"Life"},{"issue":"2","key":"8363_CR2","doi-asserted-by":"publisher","first-page":"003685042110198","DOI":"10.1177\/00368504211019854","volume":"104","author":"H Onyeaka","year":"2021","unstructured":"Onyeaka H, Anumudu CK, Al-Sharify ZT, Egele-Godswill E, Mbaegbu P. COVID-19 pandemic: A review of the global lockdown and its far-reaching effects. Sci Prog. 2021;104(2):00368504211019854.","journal-title":"Sci Prog"},{"key":"8363_CR3","doi-asserted-by":"publisher","unstructured":"Kolahchi Z, Domenico MD, Uddin LQ, Cauda V, Grossmann I, Lacasa L, et al. COVID-19 and its global economic impact. Coronavirus Disease-COVID-19: Advances in Experimental Medicine and Biology 1318. Springer; 2021;825\u201337. https:\/\/doi.org\/10.1007\/978-3-030-63761-3_46.","DOI":"10.1007\/978-3-030-63761-3_46"},{"key":"8363_CR4","unstructured":"WHO. COVID-19 strategic preparedness and response plan: 1 February 2021 to 31 January 2022 (No. WHO\/WHE\/2021.03). World Health Organization; 2021."},{"issue":"1","key":"8363_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1473-3099(21)00460-6","volume":"22","author":"M Antonelli","year":"2022","unstructured":"Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43\u201355.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"8363_CR6","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3201\/eid2704.210016","volume":"27","author":"S Amit","year":"2021","unstructured":"Amit S, Beni SA, Biber A, Grinberg A, Leshem E, Regev-Yochay G. Postvaccination COVID-19 among healthcare workers Israel. Emerg Infect Dis. 2021;27(4):1220\u20132.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"8363_CR7","first-page":"e23628","volume":"14","author":"MY Alessa","year":"2022","unstructured":"Alessa MY, Aledili FJ, Alnasser AA, Aldharman SS, Al Dehailan AM, Abuseer HO, et al. The Side Effects of COVID-19 Vaccines and Its Association With ABO Blood Type Among the General Surgeons in Saudi Arabia. Cureus. 2022;14(3):e23628.","journal-title":"Cureus."},{"key":"8363_CR8","unstructured":"Mueller B. UK approves Pfizer coronavirus vaccine, a first in the west. The New York Times. 2020;2."},{"key":"8363_CR9","unstructured":"US Food and Drug Administration. FDA approves first COVID-19 vaccine. press release, August. 2021 Apr 30;23. Accessed 1\u201312\u20132022."},{"key":"8363_CR10","doi-asserted-by":"publisher","first-page":"101113","DOI":"10.1016\/j.eclinm.2021.101113","volume":"40","author":"F Cascini","year":"2021","unstructured":"Cascini F, Pantovic A, Al-Ajlouni Y, Failla G, Ricciardi W. Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: A systematic review. EClinicalMedicine. 2021;40:101113.","journal-title":"EClinicalMedicine"},{"issue":"5","key":"8363_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/vaccines9050467","volume":"9","author":"A Pormohammad","year":"2021","unstructured":"Pormohammad A, Zarei M, Ghorbani S, Mohammadi M, Razizadeh MH, Turner DL, et al. Efficacy and safety of COVID-19 vaccines: a systematic review and meta-analysis of randomized clinical trials. Vaccines. 2021;9(5):467.","journal-title":"Vaccines"},{"key":"8363_CR12","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2147\/IJGM.S310497","volume":"14","author":"NA El-Shitany","year":"2021","unstructured":"El-Shitany NA, Harakeh S, Badr-Eldin SM, Bagher AM, Eid B, Almukadi H, et al. Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study. Int J Gen Med. 2021;14:1389.","journal-title":"Int J Gen Med"},{"key":"8363_CR13","doi-asserted-by":"publisher","first-page":"896343","DOI":"10.3389\/fpubh.2022.896343","volume":"10","author":"M Lounis","year":"2022","unstructured":"Lounis M, Rais MA, Bencherit D, Aouissi HA, Oudjedi A, Klugarov\u00e1 J, et al. Side effects of COVID-19 inactivated virus vs. adenoviral vector vaccines: experience of Algerian healthcare workers. Front Public Health. 2022;10:896343.","journal-title":"Front Public Health"},{"issue":"11","key":"8363_CR14","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.3390\/vaccines10111781","volume":"10","author":"M Lounis","year":"2022","unstructured":"Lounis M, Aouissi HA, Abdelhadi S, Rais MA, Belkessa S, Bencherit D. Short-term adverse effects following booster dose of inactivated-virus vs. adenoviral-vector COVID-19 vaccines in Algeria: A cross-sectional study of the general population. Vaccines. 2022;10(11):1781.","journal-title":"Vaccines"},{"issue":"12","key":"8363_CR15","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.1080\/21645515.2021.1977057","volume":"17","author":"V Kayser","year":"2021","unstructured":"Kayser V, Ramzan I. Vaccines and vaccination: history and emerging issues. Hum Vaccin Immunother. 2021;17(12):5255\u201368.","journal-title":"Hum Vaccin Immunother"},{"key":"8363_CR16","doi-asserted-by":"publisher","first-page":"585354","DOI":"10.3389\/fimmu.2020.585354","volume":"11","author":"O Sharma","year":"2020","unstructured":"Sharma O, Sultan AA, Ding H, Triggle CR. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19. Front Immunol. 2020;11:585354.","journal-title":"Front Immunol"},{"key":"8363_CR17","first-page":"1663","volume":"25","author":"S Meo","year":"2021","unstructured":"Meo S, Bukhari I, Akram J, Meo A, Klonoff DC. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer\/BioNTech and Moderna Vaccines. Eur Rev Med Pharmacol Sci. 2021;25:1663\u20139.","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"8363_CR18","unstructured":"Two more COVID-19 vaccines approved for use in Saudi Arabia https:\/\/www.arabnews.com\/node\/1794826\/saudi-arabia Arab News; 2022. Available from: https:\/\/arab.news\/89pmk. Accessed 1\u201312\u20132022."},{"key":"8363_CR19","unstructured":"Reynolds E, Braithwaite S, Cassidy A. Allergy warning for Pfizer\/BioNTech vaccine after UK health workers with allergy history suffer reaction. CNN. Retrieved. 2020 Dec; 9."},{"issue":"43","key":"8363_CR20","doi-asserted-by":"publisher","first-page":"5890","DOI":"10.1016\/j.vaccine.2017.08.078","volume":"35","author":"PM Luz","year":"2017","unstructured":"Luz PM, Johnson RE, Brown HE. Workplace availability, risk group and perceived barriers predictive of 2016\u201317 influenza vaccine uptake in the United States: A cross-sectional study. Vaccine. 2017;35(43):5890\u20136.","journal-title":"Vaccine"},{"key":"8363_CR21","unstructured":"UPMC. How Age and Sex Could Affect COVID-19 Vaccine Side Effects https:\/\/share.upmc.com\/2021\/04\/age-and-sex-covid-19-vaccine\/2022 [. Accessed 30\u201311\u20132022."},{"issue":"2","key":"8363_CR22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/cid\/ciaa1150","volume":"73","author":"J Zhao","year":"2021","unstructured":"Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, et al. Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility. Clin Infect Dis. 2021;73(2):328\u201331.","journal-title":"Clin Infect Dis"},{"key":"8363_CR23","doi-asserted-by":"crossref","unstructured":"Aouissi HA, Kechebar MS, Ababsa M, Roufayel R, Neji B, Petrisor AI, Hamimes A, Epelboin L, Ohmagari N. The importance of behavioral and native factors on covid-19 infection and severity: Insights from a preliminary cross-sectional study. InHealthcare. 2022;10(7):1341.","DOI":"10.3390\/healthcare10071341"},{"key":"8363_CR24","doi-asserted-by":"publisher","first-page":"237796082211032","DOI":"10.1177\/23779608221103208","volume":"8","author":"F Alhowaymel","year":"2022","unstructured":"Alhowaymel F, Abdelmalik MA, Mohammed AM, Mohamaed MO, Alenezi A. Reported side effects of COVID-19 vaccination among adults in Saudi Arabia: a cross-sectional study. SAGE Open Nursing. 2022;8:23779608221103210.","journal-title":"SAGE Open Nursing"},{"key":"8363_CR25","doi-asserted-by":"crossref","unstructured":"Almalki OS, Khalifa AS, Alhemeidi OF, Ewis AA, Shady AM, Abdelwahab SF. Correlation between the severity of COVID-19 vaccine-related adverse events and the blood group of the vaccinees in Saudi Arabia: A web-based survey. Front Pharmacol. 2022.","DOI":"10.3389\/fphar.2022.1006333"},{"key":"8363_CR26","unstructured":"EMA. Vaxzevria (previously COVID-19 Vaccine AstraZeneca).\u00a0Euro Med Agency.\u00a02022.\u00a0https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/vaxzevria. Accessed 17 Feb 2022."},{"issue":"2","key":"8363_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18549\/PharmPract.2022.2.2678","volume":"20","author":"HK Al-Qazaz","year":"2022","unstructured":"Al-Qazaz HK, Al-Obaidy LM, Attash HM. COVID-19 vaccination, do women suffer from more side effects than men? A retrospective cross-sectional study. Pharmacy Practice. 2022;20(2):1\u20136.","journal-title":"Pharmacy Practice"},{"issue":"1","key":"8363_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41182-021-00395-z","volume":"50","author":"HA Orebi","year":"2022","unstructured":"Orebi HA, Emara HE, Alhindi AA, Shahin MR, Hegazy AH, Kabbash IA, et al. Perceptions and experiences of COVID-19 vaccines\u2019 side effects among healthcare workers at an Egyptian University Hospital: a cross-sectional study. Trop Med Health. 2022;50(1):1\u201312.","journal-title":"Trop Med Health"},{"issue":"11","key":"8363_CR29","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/vaccines9111321","volume":"9","author":"I Iguacel","year":"2021","unstructured":"Iguacel I, Maldonado AL, Ruiz-Cabello AL, Casaus M, Moreno LA, Mart\u00ednez-Jarreta B. Association between COVID-19 vaccine side effects and body mass index in Spain. Vaccines. 2021;9(11):1321.","journal-title":"Vaccines"},{"issue":"12","key":"8363_CR30","doi-asserted-by":"publisher","first-page":"e2140364-e","DOI":"10.1001\/jamanetworkopen.2021.40364","volume":"4","author":"AL Beatty","year":"2021","unstructured":"Beatty AL, Peyser ND, Butcher XE, Cocohoba JM, Lin F, Olgin JE, et al. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Network Open. 2021;4(12):e2140364-e.","journal-title":"JAMA Network Open"},{"key":"8363_CR31","doi-asserted-by":"crossref","unstructured":"Kim Y, Latz CA, DeCarlo CS, Lee S, Png CM, Kibrik P, Sung E, Alabi O, Dua A. Relationship between blood type and outcomes following COVID-19 infection. InSeminars in Vascular Surgery. WB Saunders. 2021;34(3):125-31.","DOI":"10.1053\/j.semvascsurg.2021.05.005"},{"key":"8363_CR32","doi-asserted-by":"publisher","first-page":"100785","DOI":"10.1016\/j.blre.2020.100785","volume":"48","author":"N Liu","year":"2021","unstructured":"Liu N, Zhang T, Ma L, Zhang H, Wang H, Wei W, et al. The impact of ABO blood group on COVID-19 infection risk and mortality: A systematic review and meta-analysis. Blood Rev. 2021;48:100785.","journal-title":"Blood Rev"},{"issue":"2","key":"8363_CR33","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/trf.16748","volume":"62","author":"M Guti\u00e9rrez-Valencia","year":"2022","unstructured":"Guti\u00e9rrez-Valencia M, Leache L, Librero J, Jerico C, German ME, Garc\u00eda-Erce JA. ABO blood group and risk of COVID-19 infection and complications: a systematic review and meta-analysis. Transfusion. 2022;62(2):493.","journal-title":"Transfusion"},{"key":"8363_CR34","doi-asserted-by":"publisher","first-page":"105658","DOI":"10.1016\/j.micpath.2022.105658","volume":"169","author":"E Pereira","year":"2022","unstructured":"Pereira E, Felipe S, de Freitas R, Ara\u00fajo V, Soares P, Ribeiro J, et al. ABO blood group and link to COVID-19: A comprehensive review of the reported associations and their possible underlying mechanisms. Microbial Pathogenesis. 2022;169:105658.","journal-title":"Microbial Pathogenesis."},{"key":"8363_CR35","doi-asserted-by":"crossref","unstructured":"Sever P. Nocebo affects after COVID-19 vaccination. The Lancet Regional Health\u2013Europe. 2022;12.","DOI":"10.1016\/j.lanepe.2021.100273"},{"key":"8363_CR36","doi-asserted-by":"crossref","unstructured":"Lee YH, Song GG. Nocebo responses in randomized controlled trials of COVID-19 vaccines. Int J Clin Pharmacol Ther. 2022;60(1):5.","DOI":"10.5414\/CP204028"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08363-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08363-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08363-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T19:02:56Z","timestamp":1686078176000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08363-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8363"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08363-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,6]]},"assertion":[{"value":"2 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by The Scientific Research Ethical Committee at Taif University (Approval No. 43\u2013172). The online survey was anonymous. Informed consent was obtained from all participants when they accessed the online survey. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"378"}}